Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy A O'Sullivan

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Allergy and Clinical Immunology|October 19, 2017
Eosinophils and eosinophil-associated diseases: An updateJeremy A O'Sullivan, Bruce S Bochner
Frontiers in Medicine|August 22, 2017
Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding ProteinsJeremy A O'Sullivan, Daniela J Carroll, Bruce S Bochner
Frontiers in Immunology|November 1, 2021
Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death <i>In Vitro</i>Daniela J Carroll, Yun Cao, Bruce S Bochner, et al.
Frontiers in Immunology|November 6, 2023
Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cellsYun Cao, Clayton H Rische, Bruce S Bochner, et al.
Molecular Aspects of Medicine|July 14, 2022
Siglecs in allergy and asthmaBruce S Bochner, Jeremy A O'Sullivan, Alan T Chang, et al.
Seminars in Immunology|July 6, 2023
Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseasesJeremy A O'Sullivan, Bradford A Youngblood, Robert P Schleimer, et al.
Journal of Leukocyte Biology|January 23, 2020
Eosinophil and mast cell Siglecs: From biology to drug targetJeremy A O'Sullivan, Alan T Chang, Bradford A Youngblood, et al.
BMC Research Notes|April 12, 2020
Single-site, five-year experience with human eosinophil isolation by density gradient centrifugation and CD16 immunomagnetic negative separationYun Cao, Sooncheon Shin, Daniela J Carroll, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2017
Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cellsJeremy A O'Sullivan, Daniela J Carroll, Yun Cao, et al.
Molecular Immunology|January 12, 2023
NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cellsFrederick J Kohlhapp, Jeremy A O'Sullivan, Tamson V Moore, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Allergy and Clinical Immunology|October 19, 2017
Eosinophils and eosinophil-associated diseases: An updateJeremy A O'Sullivan, Bruce S Bochner
Frontiers in Medicine|August 22, 2017
Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding ProteinsJeremy A O'Sullivan, Daniela J Carroll, Bruce S Bochner
Frontiers in Immunology|November 1, 2021
Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death <i>In Vitro</i>Daniela J Carroll, Yun Cao, Bruce S Bochner, et al.
Frontiers in Immunology|November 6, 2023
Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cellsYun Cao, Clayton H Rische, Bruce S Bochner, et al.
Molecular Aspects of Medicine|July 14, 2022
Siglecs in allergy and asthmaBruce S Bochner, Jeremy A O'Sullivan, Alan T Chang, et al.
Seminars in Immunology|July 6, 2023
Siglecs as potential targets of therapy in human mast cell- and/or eosinophil-associated diseasesJeremy A O'Sullivan, Bradford A Youngblood, Robert P Schleimer, et al.
Journal of Leukocyte Biology|January 23, 2020
Eosinophil and mast cell Siglecs: From biology to drug targetJeremy A O'Sullivan, Alan T Chang, Bradford A Youngblood, et al.
BMC Research Notes|April 12, 2020
Single-site, five-year experience with human eosinophil isolation by density gradient centrifugation and CD16 immunomagnetic negative separationYun Cao, Sooncheon Shin, Daniela J Carroll, et al.
The Journal of Allergy and Clinical Immunology|July 24, 2017
Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cellsJeremy A O'Sullivan, Daniela J Carroll, Yun Cao, et al.
Molecular Immunology|January 12, 2023
NKG2D signaling shifts the balance of CD8 T cells from single cytokine- to polycytokine-producing effector cellsFrederick J Kohlhapp, Jeremy A O'Sullivan, Tamson V Moore, et al.
Pageof 3